The Role of Oxidative Stress-Mediated Inflammation in the Development of T2DM-Induced Diabetic Nephropathy: Possible Preventive Action of Tannins and Other Oligomeric Polyphenols
Diabetic nephropathy is manifested in more than 10% of people with diabetes. It is a common cause of kidney failure and end-stage kidney disease. Understanding of mechanisms underlying the initiation and development of diabetes-induced kidney injuries will allow for the development of more effective methods of prevention and treatment of the disease. Diabetic nephropathy is a wide-ranging complication of diabetes, and it is necessary to discuss the “weight” of pro-inflammatory pathways and molecules in the progress of renal injuries during the development of the disease. A large spectrum of pro-inflammatory molecules and pathways participate in different stages of the pathophysiological progression of diabetic nephropathy, including pro-inflammatory cytokines, chemokines, their receptors, adhesion molecules, and transcription factors. On the other hand, it is known that one of the consequences of hyperglycemia-induced ROS generation is the up-regulation of pro-inflammatory cascades, which, in turn, activate the transcription of genes encoding cytokines-chemokines, growth factors, and extracellular matrix proteins. It is a proven fact that a variety of plant secondary metabolites, such as tannins, flavonoids, and other polyphenols, demonstrate significant anti-diabetic, redox-modulating properties and effectively modulate the inflammatory response. Thus, this review is discussing the possible role of plant phenols in the prevention and treatment of diabetic nephropathy.
Топ-30
Журналы
|
1
2
3
4
|
|
|
International Journal of Molecular Sciences
4 публикации, 7.84%
|
|
|
Molecules
2 публикации, 3.92%
|
|
|
Life
2 публикации, 3.92%
|
|
|
Frontiers in Nutrition
1 публикация, 1.96%
|
|
|
Biomedicines
1 публикация, 1.96%
|
|
|
Current Issues in Molecular Biology
1 публикация, 1.96%
|
|
|
Pharmaceuticals
1 публикация, 1.96%
|
|
|
Journal of Ethnopharmacology
1 публикация, 1.96%
|
|
|
Inflammopharmacology
1 публикация, 1.96%
|
|
|
Asian Pacific Journal of Tropical Biomedicine
1 публикация, 1.96%
|
|
|
Nutrients
1 публикация, 1.96%
|
|
|
Medicina
1 публикация, 1.96%
|
|
|
Current Pharmacology Reports
1 публикация, 1.96%
|
|
|
Pharmaceutics
1 публикация, 1.96%
|
|
|
Diabetes
1 публикация, 1.96%
|
|
|
Egyptian Journal of Basic and Applied Sciences
1 публикация, 1.96%
|
|
|
Frontiers in Endocrinology
1 публикация, 1.96%
|
|
|
Biological Research
1 публикация, 1.96%
|
|
|
Biomedicine and Pharmacotherapy
1 публикация, 1.96%
|
|
|
Applied Biochemistry and Biotechnology
1 публикация, 1.96%
|
|
|
Wound Repair and Regeneration
1 публикация, 1.96%
|
|
|
Indian Journal of Clinical Biochemistry
1 публикация, 1.96%
|
|
|
BMC Complementary Medicine and Therapies
1 публикация, 1.96%
|
|
|
PLoS ONE
1 публикация, 1.96%
|
|
|
Food Research International
1 публикация, 1.96%
|
|
|
South African Journal of Botany
1 публикация, 1.96%
|
|
|
Lipids in Health and Disease
1 публикация, 1.96%
|
|
|
Plants
1 публикация, 1.96%
|
|
|
ACS Omega
1 публикация, 1.96%
|
|
|
1
2
3
4
|
Издатели
|
2
4
6
8
10
12
14
16
|
|
|
MDPI
16 публикаций, 31.37%
|
|
|
Springer Nature
10 публикаций, 19.61%
|
|
|
Elsevier
7 публикаций, 13.73%
|
|
|
Wiley
4 публикации, 7.84%
|
|
|
Frontiers Media S.A.
3 публикации, 5.88%
|
|
|
Research Square Platform LLC
2 публикации, 3.92%
|
|
|
Medknow
1 публикация, 1.96%
|
|
|
American Diabetes Association
1 публикация, 1.96%
|
|
|
Taylor & Francis
1 публикация, 1.96%
|
|
|
Public Library of Science (PLoS)
1 публикация, 1.96%
|
|
|
American Chemical Society (ACS)
1 публикация, 1.96%
|
|
|
Royal Society of Chemistry (RSC)
1 публикация, 1.96%
|
|
|
Georg Thieme Verlag KG
1 публикация, 1.96%
|
|
|
Hindawi Limited
1 публикация, 1.96%
|
|
|
2
4
6
8
10
12
14
16
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.